Posted December 22, 2017
Recently we told you about the Nov. 20-21 meeting of the FDA’s Pharmacy Compounding Advisory Committee (PCAC), in which the committee would recommend whether several natural medicines could continue to be used by pharmacies to make customized natural medicines for patients. The fate of several crucial medicines was decided, including resveratrol, astralagus, and pregnenolone. Read more.